Table 2.
Baseline characteristics of the participants based on gender.
| Variables | Total (n = 312) | Male (n = 225) | Female (n = 87) | p-value |
|---|---|---|---|---|
| Age, year | 43.3 ± 12.6 | 42.9 ± 12.6 | 44.3 ± 12.6 | 0.387 |
| Height, cm | 162.1 ± 9.3 | 164.8 ± 7.1 | 151.7 ± 7.5 | 0.000 |
| Weight, kg | 65.2 ± 11.7 | 68.1 ± 10.6 | 57.9 ± 11.4 | 0.000 |
| BMI, kg/m2 | 25.2 ± 3.7 | 25 ± 3.4 | 25.6 ± 4.5 | 0.249 |
| WC, cm | 86.6 ± 10.4 | 87.8 ± 10.2 | 84 ± 10.6 | 0.015 |
| HC, cm | 92.7 ± 8.7 | 92.2 ± 8.2 | 90.7 ± 8.2 | 0.203 |
| SBP, mmHg | 130.2 ± 17.9 | 130.1 ± 17.5 | 130.6 ± 18.8 | 0.830 |
| DBP, mmHg | 84.5 ± 10 | 84.3 ± 10.3 | 85 ± 9.4 | 0.559 |
| FBG, mmol/dL | 7.3 ± 3.7 | 6.9 ± 3.6 | 8.2 ± 4 | 0.024 |
| SUA, mg/dL | 5.4 ± 1.8 | 5.9 ± 1.6 | 4.4 ± 1.7 | 0.000 |
| XO, U/L | 4.4 ± 2.8 | 3.9 ± 2.5 | 5.8 ± 3.2 | 0.000 |
| Creatinine, mg/dL | 0.9 ± 0.3 | 0.9 ± 0.3 | 0.7 ± 0.2 | 0.000 |
| TG, mg/dL | 199.7 ± 122.8 | 201.6 ± 18.3 | 194.9 ± 134.4 | 0.703 |
| TC, mg/dL | 217.7 ± 87.1 | 213.6 ± 82.5 | 228.1 ± 97.9 | 0.248 |
| HDL-C, mg/dL | 34.3 ± 13.6 | 34.1 ± 14.4 | 36.4 ± 10.9 | 0.160 |
| LDL-C, mg/dL | 144.2 ± 80.3 | 140.1 ± 72.6 | 154.8 ± 97.4 | 0.170 |
| Hypertension, (%) | 41.9 | 42.2 | 41.4 | – |
Values are presented as mean ± SD. p-values are obtained from the independent sample t-test.
BMI, body mass index; WC, waist circumference; HC, hip circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; XO, xanthine oxidase; SUA, serum uric acid; FBG, fasting blood glucose; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.